Patient Recruitment/Retention Featured Articles

  1. Operationalizing A Diversity Action Plan That Makes An Impact 8/19/2024

    In part two of this series on creating a diversity action plan (DAP), Elevate Advocacy's Devra Densmore shares a detailed plan for creating a DAP that meets FDA expectations.

  2. The Future Of MDMA-Assisted Therapy After FDA Rejection — Where Do We Go Now? 8/16/2024

    After the recent FDA rejection of MDMA-assisted therapy for PTSD, psychedelic drug developers and mental health experts alike are asking (and answering), "Where do we go now?"

  3. Creating More Equitable Clinical Trials With Health Systems Science 8/15/2024

    Belmont University Center for Health Systems Science Chair Douglas P. Slakey, MD, MPH explains how using health systems science to inform clinical trial design, implementation, and interpretation is crucial for achieving more equitable and effective patient outcomes.

  4. Diversity Action Plan (DAP): Creating An Ecosystem For Success 8/12/2024

    In part one of this two-part series, Elevate Advocacy Founder Devra Densmore explores how to create an ecosystem in which a successful diversity action plan (DAP) can be written and executed.

  5. How Patient-Centric Approaches Are Shaping The Future Of CGT 8/6/2024

    Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.

  6. Want More Diverse Enrollment? Slow Down And Listen To Patients 8/2/2024

    Getting more diverse patients enrolled in clinical trials isn't an easy task, but Teri Crumb, MSN, RN, CCRC says it could be as simple as taking the time to understand and then meet patients' needs.

  7. Government Contract Advances Walgreens In Clinical Space 8/1/2024

    Walgreen’s new $25 million deal with BARDA (Biomedical Advanced Research and Development Authority) is a huge win for the pharmacy chain. John Campbell, head of DCTs at Walgreens, explains the ins and outs of the study and what could be next for the company regarding its clinical trials division.

  8. 5 Drivers Of Patient Financial Toxicity — And 10 Tips To Address Them 7/30/2024

    Clinical research administrator Tina Bowdish points to five causes of financial toxicity for patients participating in clinical trials and offers 10 ways to address them.

  9. Siteless DCTs Are Real … And Happening Now 6/20/2024

    Siteless DCTs (decentralized trials) are rare, but Praxis Precision Medicines is running one now for patients with essential tremor (ET). Marcio Souza, PharmD, the company’s president and CEO, talks about why they chose this model and the surprising speed at which it is progressing.

  10. 4 Tips For Diverse Recruiting In Dermatologic Clinical Trials 6/17/2024

    Diverse patient recruitment in dermatologic clinical trials is imperative for addressing health disparities and advancing equitable care. Alain Michon, MD defines those disparities, describes why they exist, and offers four tips for offering underserved patients better care.